Navigation Links
Vestergaard Frandsen to Launch High Tech Filter to Provide Clean and Safe Drinking Water to People in Developing Nations
Date:2/5/2008

Instant Microbiological Purifier Provides Homemade Drinking Water with

Potential to Save Lives and Reduce Suffering on a Massive Scale

WASHINGTON, Feb. 5 /PRNewswire/ -- Vestergaard Frandsen, a European company that develops award-winning products to save lives and reduce suffering in the developing world, will unveil LifeStraw(R) Family -- a new point-of-use product designed to allow consumers in the developing world to create their own safe and healthy homemade drinking water.

Time & Location: The National Press Club

529 14th Street, NW Washington DC

February 7, 2008

12:30 - 2 PM

Speakers: Mikkel Vestergaard Frandsen-CEO of Vestergaard

Frandsen, Switzerland

Dr. Thomas Clasen, The London School of

Hygiene and Tropical Medicine

Media Info: Product will be demonstrated

For more information about Vestergaard Frandsen please visit http://www.vestergaard-frandsen.com.


'/>"/>
SOURCE Vestergaard Frandsen
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ALLAHASSEE, Fla. -- A Florida State University Col...g has discovered an important new layer of regulat...o a greater understanding of the way cancer begins...ciences at the College of Medicine, said the findi...ancer and could lead to the design of new drugs th...
(Date:11/21/2008)...SBURG, Pa., Nov. 21 Du...overnor Edward G. Rendell today remembered Lieuten...eacher, an important partner in public service, an...ia. , , "As the first woman elected lieuten...blic servant," said Governor Rendell. "Her family ...
(Date:11/21/2008)...N, Ariz., Nov. 21 The Pr...day announced that Craig A. Norris, the Company,s,...e Company,s Board of,Directors. Mr. Norris, appo...resignation of Steven I. Geringer and returns the ...on any committee of the Board. , Mr. Norris...
(Date:11/21/2008)...esearchers remain cautious about future antibiotic...IDAY, Nov. 21 (HealthDay News) -- People with mode...se (COPD) may be able to reduce the frequency of e...on antibiotic, a new report says. , The study,... American Journal of Respiratory and Critical Care...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:Long-Term Erythromycin Cut COPD Complications 2
...ecent study researchers say cholesterol may be act...cells healthy , however researchers also say that ...used inside the arteries, where it builds up as pl...okes. Researchers suggest an enzyme called ACAT2 m...
...an Medical Association, a recent study had shown t...sk of developing in next 20 years. Scientists have...agnosed with clinically localized prostate cancer ...observation or immediate or delayed androgen withd...
...lly created a new breed of mice that can reduce fr...or themselves.// The reactive oxygen of the free r... may lead to poor health and even death. The new r... towards increasing mortality through the free rad...
...be two separate conditions that frequently co-exis...umatism say that it is essential to treat depressi...imultaneously. The researchers had studied 33 wome...s the condition where patient feels extensive tend...
Other Medicine News:
(Date:11/20/2008)...SE III TRIAL SHOW SIGNIFICANT, DECREASES IN P..., IN, FIBROMYALGIA PAT...ium, Nov. 20 /PRNewswire-FirstCall/,-- Jazz Pharm...xt Brussels: UCB),announced today positive prelim...e III pivotal clinical trials of sodium oxybate (J...
(Date:11/20/2008)...Call/ -- Bionovo, Inc.,(Nasdaq: BNVI ) announce...1B,clinical trial of their lead drug candidate fo...he Society for Integrative Oncology,s Fifth Intern...any,s oral presentation was selected,as a top sco...he Best of the,SIO Session on November 20, 2008. ...
(Date:11/20/2008)...ta from a prospective,registry presented this wee...eatment with the Trellis(R) Peripheral Infusion Sy...) successfully breaks up the blood clot in most,p...ue, called isolated pharmacomechanical thrombolysi...an current catheter-directed thrombolysis,(CDT) t...
(Date:11/19/2008)...Science Corporation,researcher, Dan Tinker, prese...ual Conference in Washington, DC this week indicat...ers. The computerized brain plasticity-based,Bra...at target auditory and,language systems. The exe...ents in cognition by improving speed and accuracy ...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Using Early Stage Commercialization Activities to Build Long Term Success for the Bottom Line 8451 1Using Early Stage Commercialization Activities to Build Long Term Success for the Bottom Line 8451 2This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 1This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 2This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 3GeneGo Integrates With Cytoscape 2266 1GeneGo Integrates With Cytoscape 2266 2Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use 2264 1Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use 2264 2
...07 - Roche today announced,results of a small stud... treatment with Peg-Intron(R) (peginterferon alfa-... first 12 weeks, were,able to complete 12 weeks of... and ribavirin. Furthermore, 92 percent of,these p...rse of,treatment with PEGASYS. The data, which wer...
...rstCall/ -- Bristol-Myers,Squibb Company (NYSE: BM...ich showed that treatment with Baraclude (entecavi...adefovir at 48 weeks,-- a result that was also see...a from an open-label, randomized viral kinetics st...tigen (HBeAg),positive patients were presented at ...
Other Medicine Technology:Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 2Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 3Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 4Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 5Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 6Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
...um Eppendorf Style Low Binding, Graduated Pipet Ti...Pipettors.Reduces DNA and protein binding. Non-rea... completely by automation. RNAse & DNAse free. AVR...nd 10 racks/cs. AVR100 is the Cell Rack packaged 9...
Packed conveniently in plastic-wrapped racks of 96 tips, Sterilized Diamond- Tips are ready to useno need to autoclave. Sterilized Diamond Tips are irradiated by gamma-rays for more efficient sterili
Like all Gilson disposable pipette tips, TowerPacks are available in a sterilized version. Each Sterilized TowerPack is individually wrapped in medical device-quality plastic to help protect tips fro
Medicine Products: